Newsmeme!
Discover News you didn't know existed
Larynx
News
ViroPharma Submits Supplemental Biologics License Application for Cinryze(TM) to Treat Acute Attacks of Hereditary ...
Published December 1, 2008, 2:20 pm, PR Newswire via Yahoo! Finance
ViroPharma Incorporated today announced that the company submitted a supplemental Biologics License Application to the U.S. Food and Drug Administration for Cinryze C1 Inhibitor as a treatment for acute attacks of hereditary angioedema .
Tags
No tags found at this time. Be the first to tag this news item, learn more.
Imagery
Related Larynx Stories
From Various News Sources
ViroPharma Inc. submits sBLA for Cinryze to treat acute attacks of ... - News-Medical.Net
ViroPharma Inc. has announced that the company submitted a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration (FDA) for Cinryze C1 Inhibitor (human) as a treatment for acute attacks of hereditary angioedema ...
Related Social Bookmarks
None found at this time.
Related News Resources:
> HGH News
News Directory
Get started fast by using a pre-defined news directory category
|
Breaking News
and Top Stories |
Business
Earnings, Economy, Personal Finance, and Stock Markets |
Entertainment
Books, Celebrity, Fashion, Movies, Music, Television, and Theatre |
Health
Aging, Diseases, Medical Conditions, Medications, Sexual Health, and Weight Loss |
Politics
Congress, Supreme Court, and White House |
|
Science
Animals, Astronomy, Biotechnology, Space, and Weather |
Sports
Baseball, Basketball, Boxing, Football, Golf, Hockey, Motor Sports, Soccer, and Tennis |
Technology
Communications, Hardware, Internet, Personal Technology, and Software |
United States
and Crimes and Trials |
World
Africa, Antartica, Asia, Australia, Canada, Europe, Latin America, and Middle East |